SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Collins who wrote (51)10/3/1996 12:36:00 PM
From: Harold Engstrom   of 305
 
Biotechs can be predictable, but usually there is a run up in the stock price weeks in advance of the anticipated Phase III announcements and then the stock usually falls slightly upon the news (unless it is bad, in which case it falls a lot). If you believe IMUL will have some positive announcements in Feb., then you should probably buy your stock and options during the next few weeks.

Harold Engstrom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News